Alaunos Therapeutics, Inc. reported a net loss of $4.2M in fiscal year 2025. This represents an increase of 10.8% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Alaunos Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TCRT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.2M+10.8% | -$4.7M0.0% | -$4.7M+87.6% | -$37.7M+52.1% | -$78.8M+1.5% | -$80.0M+32.1% | -$117.8M-121.8% | -$53.1M+2.2% | -$54.3M+67.1% | -$165.3M-37.6% | -$120.1M-277.9% | -$31.8M+44.3% | -$57.1M+40.6% | -$96.1M-50.7% | -$63.8M |
TCRT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Alaunos Therapeutics, Inc. financials
Frequently Asked Questions
What was Alaunos Therapeutics, Inc.'s net income in fiscal year 2025?
Alaunos Therapeutics, Inc. reported a net loss of $4.2M in fiscal year 2025.
How fast is Alaunos Therapeutics, Inc.'s net income growing?
Alaunos Therapeutics, Inc. (TCRT) net income rose by 10.8% year over year, from -$4.7M to -$4.2M in fiscal year 2025.
How has Alaunos Therapeutics, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Alaunos Therapeutics, Inc. (TCRT) net income went from -$63.8M in fiscal year 2011 to -$4.2M in fiscal year 2025.
What was Alaunos Therapeutics, Inc.'s net income in the most recent quarter?
Alaunos Therapeutics, Inc. (TCRT) reported -$952K in net income in Q2 2026. This represents an increase of 9.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Alaunos Therapeutics, Inc. (TCRT) reported on that line in every period on record.